Regenxbio (RGNX) Assets Average (2015 - 2025)

Regenxbio's Assets Average history runs 11 years deep, the most recent figure standing at $489.1 million for Q4 2025.

• In Q4 2025, Assets Average fell 0.7% year-over-year to $489.1 million; the TTM figure through Dec 2025 stood at $489.1 million (down 0.7% YoY), while the FY2025 annual figure was $459.5 million, down 11.63% from the prior year.
• Assets Average was $489.1 million for Q4 2025 at Regenxbio, down from $553.1 million in the prior quarter.
• In the past five years, Assets Average ranged from a high of $1.1 billion in Q1 2022 to a low of $478.5 million in Q1 2025.
• Historically, Assets Average has averaged $716.3 million across 5 years, with a median of $686.6 million in 2023.
• The sharpest annual moves came in 2021 and 2023: Assets Average jumped 87.8% in 2021, then dropped 29.66% in 2023.
• A 5-year view of Assets Average shows it stood at $957.1 million in 2021, then slipped by 10.3% to $858.5 million in 2022, then decreased by 29.66% to $603.9 million in 2023, then dropped by 18.44% to $492.6 million in 2024, then decreased by 0.7% to $489.1 million in 2025.
• The last three Assets Average figures came in at $489.1 million (Q4 2025), $553.1 million (Q3 2025), and $536.0 million (Q2 2025), per Business Quant data.